Herbalife Nutrition Ltd.

Herbalife Nutrition Ltd. (NYSE:HLF) is a global nutrition company founded in 1980 and headquartered in Los Angeles, California. The company went public in 2004 and operates through a multi-level marketing business model, selling nutrition and wellness products through a network of independent distributors across more than 90 countries. Originally known as Herbalife Ltd., the company rebranded to Herbalife Nutrition Ltd. in 2018 to emphasize its focus on nutrition solutions. The company has faced significant regulatory scrutiny over its business practices, including a $200 million settlement with the FTC in 2016, but continues to operate as one of the world's largest direct-selling nutrition companies.

Over the past two years, Herbalife has undergone significant strategic transformation focused on digital modernization and distributor support enhancement. The company completed a major restructuring program that exceeded cost savings targets, generating $115 million in annual savings compared to the original $70 million goal. A key initiative has been the development and launch of the Herbalife One digital platform, representing approximately $400 million in investment to modernize the distributor experience with improved ordering, training, and customer management tools. This digital transformation aims to address productivity challenges among distributors recruited during the pandemic who have underperformed compared to pre-pandemic cohorts. The company has prioritized distributor recruitment and retention through several new programs. The Herbalife Premier League program and partnership with direct-selling trainer Eric Worre have helped reverse 12 consecutive quarters of recruiting decline, achieving 22% new distributor growth in Q4 2024. The Diamond Development Mastermind Program provides enhanced training and support for top-performing distributors. Recent strategic acquisitions include Pro2col Health, Pruvit Ventures, and Link BioSciences, with the Pro2col platform representing a significant move toward AI-powered personalization. The Pro2col digital health application is scheduled for beta launch in July 2025 and commercial release in Q4 2025, potentially creating new revenue streams through app fees and personalized product offerings. Leadership changes include the appointment of Stephan Gratziani as CEO effective May 2024, with founder Michael Johnson transitioning to Executive Chairman, signaling a new phase of professional management focused on operational excellence and growth recovery.